Effect of conjugated linoleic acid on bone formation and rheumatoid arthritis

Eur J Pharmacol. 2007 Jul 30;568(1-3):16-24. doi: 10.1016/j.ejphar.2007.04.056. Epub 2007 May 22.

Abstract

Conjugated linoleic acid (CLA) has shown a variety of biologically beneficial effects. Dietary CLA inhibits eddosteal bone resorption, increases endocortical bone formation, and modulates the action and expression of cyclooxygenase (COX) enzyme, thereby decreasing prostaglandin-dependent bone resorption. CLA also enhances calcium absorption and may improve bone formation in animals, although results are not consistent. Since CLA can also affect inflammatory cytokines, it is hypothesized that CLA may be a good tool for prevention or reduction of rheumatoid arthritis symptoms. The possible mechanisms by which CLA prevents rheumatoid arthritis as well as other inflammatory diseases is discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / prevention & control
  • Cytokines / metabolism
  • Humans
  • Inflammation / drug therapy
  • Linoleic Acids, Conjugated / pharmacology*
  • Osteogenesis / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Linoleic Acids, Conjugated